7
total announcements
539871.BO · 15 min delayed
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd has made available the audio recording of its earnings conference call for the quarter ended June 30, 2026, on its website at https://investor.thyrocare.com/financials/quarterly-financial-results/. The transcript will be shared shortly.
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd has announced the in-principle approval of its Board of Directors for the evaluation of a proposed demerger of its wholly-owned subsidiary Nueclear Healthcare Limited's radiology business.
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd has announced the re-appointment of Ernst & Young LLP as its Internal Auditor for the Financial Year 2026-27. The company has also approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd has released its unaudited financial results for Q1 FY27, showing a 24% YoY revenue growth and 34% YoY PAT growth. The company has also launched new laboratories, expanded its capabilities, and strengthened its relationships with channel partners.
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd reported Q1FY27 results with revenue of INR 240.02 Cr, a 24% YoY growth, driven by a 26% increase in the Pathology segment. EBITDA grew by 34% YoY to INR 77.27 Cr, and PAT grew by 34% YoY to INR 51.33 Cr. The company expanded into Specialty Diagnostics, marking the next phase of its growth journey.
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report. The Board has approved the results, and the company has also re-appointed Ernst & Young LLP as its Internal Auditor for the Financial Year 2026-27.
Thyrocare Technologies Ltd
Thyrocare Technologies Ltd announced the outcome of its Board Meeting held on July 23, 2026, where it approved unaudited financial results for the quarter ended June 30, 2026, and re-appointed Ernst & Young LLP as Internal Auditor for the Financial Year 2026-27.